MYLAN 8110 Pill — PINK;YELLOW CAPSULE, 23mm — Atomoxetine

No photo available

Imprint	MYLAN / 8110
Colour	PINK;YELLOW
Shape	CAPSULE
Size	23
Strength	ATOMOXETINE 100 mg
Dosage form	Capsule
Manufacturer	Mylan Pharmaceuticals Inc.
NDC	0378-8110
Schedule	—
Availability	—
Ingredients	ATOMOXETINE HYDROCHLORIDE[ATOMOXETINE]

What does this imprint mean?

The imprint "MYLAN 8110" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Atomoxetine

Uses and warnings

BOXED WARNING: Suicidal Ideation - "STRATTERA increased the risk of suicidal ideation in short-term studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD)." Patients started on therapy "should be monitored closely for suicidality (suicidal thinking and behavior), clinical worsening, or unusual changes in behavior." Additional warnings cover "Severe Liver Injury" (discontinue if jaundice or lab evidence of liver injury occurs), "Serious Cardiovascular Events" including sudden death in patients with structural cardiac abnormalities, effects on blood pressure and heart rate requiring monitoring, and emergence of new psychotic or manic symptoms; screening for bipolar disorder is advised before starting.

STRATTERA is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). The label notes it should be used as part of "a total treatment program for ADHD that may include other measures (psychological, educational, social)."

Read the full drug profile →